DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE
$441,905N43FY2016AINIH
Pai Life Sciences, Inc., Seattle WA
Investigators
Abstract
To develop an onchocerciasis vaccine to be used for disease control and elimination.
View original record on NIH RePORTER →